Jan 13, 2022
Ro Khanna- Amount
- Receipt pending ingestion
- Filed
- May 6, 2022
Congress ticker disclosure profile
As of August 1 at 7:35 AM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference QGEN. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
10
Member filers
4
Disclosed ranges
Amount not disclosed
Most active member desks
6 sells vs 4 buys
Latest trade Jan 13, 2022
Jan 13, 2022
Ro KhannaApr 7, 2020
Ro KhannaMar 24, 2020
Peter WelchFeb 27, 2020
Peter WelchOct 8, 2019
Alan S. LowenthalSep 13, 2019
Alan S. LowenthalSep 12, 2019
Alan S. LowenthalJan 23, 2019
Donna ShalalaJan 9, 2019
Donna ShalalaFeb 28, 2017
Alan S. Lowenthal| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Jan 13, 2022 | Ro Khanna | Sell | Receipt pending ingestion | May 6, 2022 | Open card |
| Apr 7, 2020 | Ro Khanna | Sell | Receipt pending ingestion | May 13, 2020 | Open card |
| Mar 24, 2020 | Peter Welch | Sell | Receipt pending ingestion | Apr 3, 2020 | Receipt pending ingestion |
| Feb 27, 2020 | Peter Welch | Buy | Receipt pending ingestion | Mar 10, 2020 | Receipt pending ingestion |
| Oct 8, 2019 | Alan S. Lowenthal | Sell | Receipt pending ingestion | Nov 8, 2019 | Receipt pending ingestion |
| Sep 13, 2019 | Alan S. Lowenthal | Buy | Receipt pending ingestion | Sep 21, 2019 | Receipt pending ingestion |
| Sep 12, 2019 | Alan S. Lowenthal | Buy | Receipt pending ingestion | Sep 21, 2019 | Receipt pending ingestion |
| Jan 23, 2019 | Donna Shalala | Sell | Receipt pending ingestion | Apr 27, 2020 | Open card |
| Jan 9, 2019 | Donna Shalala | Sell | Receipt pending ingestion | Apr 27, 2020 | Open card |
| Feb 28, 2017 | Alan S. Lowenthal | Buy | Receipt pending ingestion | Mar 7, 2017 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 0 of 10 filed rows include disclosed amount ranges (0.0%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.